Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
DSP Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesCipla Limited8.75561790481269.1630
Domestic EquitiesSun Pharmaceutical Industries Limited7.96371535592244.8194
Domestic EquitiesCohance Lifesciences Limited7.90422764085242.9907
Domestic EquitiesIPCA Laboratories Limited7.38881696381227.1454
Domestic EquitiesLaurus Labs Limited6.07322217884186.7015
Domestic EquitiesGland Pharma Limited5.9646920673183.3612
Domestic EquitiesSai Life Sciences Limited4.76811703020146.5789
Domestic EquitiesApollo Hospitals Enterprise Limited4.6940194767144.3029
Domestic EquitiesAlembic Pharmaceuticals Limited4.18741428180128.7290
Domestic EquitiesKovai Medical Center and Hospital Limited3.2949165156101.2902
Domestic EquitiesPfizer Limited3.2869200644101.0443
Domestic EquitiesProcter & Gamble Health Limited3.2682159288100.4709
Domestic EquitiesIndoco Remedies Limited3.0708323347494.4013
Domestic EquitiesVijaya Diagnostic Centre Limited3.043293553093.5530
Domestic EquitiesConcord Biotech Limited2.625148977480.7001
Domestic EquitiesEmcure Pharmaceuticals Limited1.637439328950.3371
Domestic EquitiesICICI Lombard General Insurance Company Limited1.484024141345.6222
Domestic EquitiesAarti Drugs Limited1.348685215541.4573
Domestic EquitiesUnichem Laboratories Limited1.278985206339.3142
Domestic EquitiesThyrocare Technologies Limited0.693418366921.3166
Domestic EquitiesAlkem Laboratories Limited0.65883733420.2537
Domestic EquitiesMedplus Health Services Limited0.473319207814.5489
Domestic EquitiesJupiter Life Line Hospitals Limited0.46569411714.3143
Domestic EquitiesLaxmi Dental Limited0.29662804019.1186
Total 84.6253 2601.5347
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments2.3413 71.9764
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.2958 -9.0934
Total 2.0455 62.8830
Overseas EquitiesGlobus Medical Inc4.4463268800136.6884
Overseas EquitiesIllumina Inc4.3998160400135.2590
Overseas EquitiesIntuitive Surgical Inc2.42431876874.5288
Overseas EquitiesAbbott Laboratories1.22253160037.5814
Overseas EquitiesGrail Inc0.149187334.5851
Total 12.6422 388.6427
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.68706125021.1192
Total 0.6870 21.1192
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.